Mirum Pharmaceuticals Newsroom

Analysts Are Bullish on These Healthcare Stocks: Annexon Biosciences (ANNX), Mirum Pharmaceuticals (MIRM)

TipRanksNov 21 20:15

Evercore Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $68

Futu NewsNov 14 21:35

Mirum Pharmaceuticals Price Target Maintained With a $66.00/Share by HC Wainwright & Co.

Dow JonesNov 14 03:06

Morgan Stanley Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $60

Futu NewsNov 13 21:34

A Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $50 to $70

Futu NewsNov 13 21:06

Mirum Pharmaceuticals Is Maintained at Outperform by Baird

Dow JonesNov 13 20:32

Mirum Pharmaceuticals Analyst Ratings

BenzingaNov 13 20:22

Promising Outlook for Mirum Pharmaceuticals: Buy Rating Justified by Strong Performance and Strategic Initiatives

TipRanksNov 13 19:06

Mirum Pharmaceuticals Is Maintained at Outperform by Leerink Partners

Dow JonesOct 17 22:55

Leerink Partners Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $49

Futu NewsOct 17 20:31

Mirum Pharmaceuticals Analyst Ratings

BenzingaOct 11 18:48

H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $66

Futu NewsOct 11 18:31

Evercore ISI Raises Price Target on Mirum Pharmaceuticals to $66 From $62, Keeps Outperform Rating

MT NewswiresAug 26 19:29

Optimistic Buy Rating for Mirum Pharmaceuticals Amidst Strong Sales Growth and Expanded LIVMARLI Label

TipRanksAug 8 22:06

Mirum Pharmaceuticals (MIRM) Receives a Buy From Evercore ISI

TipRanksAug 8 22:06

Baird Maintains Outperform on Mirum Pharmaceuticals, Raises Price Target to $44

BenzingaAug 8 20:03

Mirum Pharmaceuticals Analyst Ratings

BenzingaAug 8 20:03

Mirum Pharmaceuticals Price Target Maintained With a $66.00/Share by HC Wainwright & Co.

Dow JonesJul 26 19:31

Mirum Pharmaceuticals Analyst Ratings

BenzingaJul 26 19:25

H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $66

Futu NewsJul 26 18:33